Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution

References

• Cai D, Gao W, He B, Dai W, Zhang H, Wang X, et al. 2014. Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy. Biomaterials. 35:2283–2294.
   PubMed Web of Science ®Google Scholar
• Chen J, Lin A, Chen Z, Wang W, Zhang T, Cai H, Cai B. 2010. Ammonium sulfate gradient loading of brucine into liposomes: effect of phospholipid composition on entrapment efficiency and physicochemical properties in vitro. Drug Dev Ind Pharm. 36:245–253.
   PubMed Web of Science ®Google Scholar
• Crosasso P, Ceruti M, Brusa P, Arpicco S, Dosio F, Cattel L. 2000. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release. 63:19–30.
   PubMed Web of Science ®Google Scholar
• Dorr RT. 1994. Pharmacology and toxicology of Cremophor EL diluents. Ann Pharmacother. 28:511–514.
   Google Scholar
• Hofheinz RD, Gnad-Vogt SU, Beyer U, Hochhaus A. 2005. Liposomal encapsulated anticancer drugs. Anticancer Drugs. 16:691–707.
   PubMed Web of Science ®Google Scholar
• Jain RK. 1987. Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 6:559–593.
   PubMed Web of Science ®Google Scholar
• Kramer I, Heuser A. 1995. Paclitaxel pharmaceutical and pharmacological issues. Eur Hosp Pharm. 1:37–41.
   Web of Science ®Google Scholar
• Maeda H, Matsumura Y. 1989. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst. 6:193–210.
   PubMed Web of Science ®Google Scholar
• Okamoto I, Sakai K, Morita S, Yoshioka H, Kaneda H, Takeda K, et al. 2014. Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study. Oncotarget. 5:2293–2304.
   PubMed Web of Science ®Google Scholar
• Sur S, Fries AC, Kinzler KW, Zhou S, Vogelstein B. 2014. Remote loading of preencapsulated drugs into stealth liposomes. Proc Natl Acad Sci USA. 111:2283–2288.
   PubMed Web of Science ®Google Scholar
• Umrethia M, Ghosh PK, Majithya R, Murthy RS. 2007. 6-Mercaptopurine (6-MP) entrapped stealth liposomes for improvement of leukemic treatment without hepatotoxicity and nephrotoxicity. Cancer Invest. 25:117–123.
   PubMed Web of Science ®Google Scholar
• Uster PS, Allen TM, Daniel BE, Mendez CJ, Newman MS, Zhu GZ. 1996. Insertion of poly (ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett. 386:243–246.
   PubMed Web of Science ®Google Scholar
• Wang H, Cheng G, Du Y, Ye L, Chen W, Zhang L, et al. 2013. Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation. Mol Med Rep. 7:947–952.
   PubMed Web of Science ®Google Scholar
• Zhang MC, Taylor HL, Wall ME, Coqqon P, McPhail AT. 1971. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 93:2325–2327.
   PubMed Web of Science ®Google Scholar
• Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, et al. 1990. Hypersensitivity reactions from taxol. J Clin Oncol. 8:1263–1268.
   PubMed Web of Science ®Google Scholar
• Woodle MC, Lasic DD. 1992. Sterically stabilized liposomes. BBA-Biomembr. 1113:171–199.
   PubMed Web of Science ®Google Scholar
• Xu X, Wang L, Xu HQ, Huang XE, Qian YD, Xiang J. 2013. Clinical comparison between paclitaxel liposome (Lipusu®) and paclitaxel for treatment of patients with metastatic gastric cancer. Asian Pac J Cancer Prev. 14:2591–2594.
   PubMed Web of Science ®Google Scholar
• Yang G, Yang T, Zhang W, Lu M, Ma X, Xiang G. 2014. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome. J Agric Food Chem.; 62:2207–2215.
   PubMed Web of Science ®Google Scholar
• Ye L, He J, Hu Z, Dong Q, Wang H, Fu F, Tian J. 2013. Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts. Food Chem Toxicol. 52:200–206.
   PubMed Web of Science ®Google Scholar
• Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. 1995. Vascular permeability in a human tumor xenograft — molecular-size dependence and cutoff size. Cancer Res. 55: 3752–3756.
   PubMed Web of Science ®Google Scholar
• Zhang HL, Ruan L, Zheng LM, Whyte D, Tzeng CM, Zhou XW. 2012. Association between class III β-tubulin expression and response to paclitaxel/vinorebine-based chemotherapy for non-small cell lung cancer: a meta-analysis. Lung Cancer. 77: 9–15.
   PubMed Web of Science ®Google Scholar